01st February 2022 | Pharma Updates
PharmaState Updates – Latest Pharma Happenings Infalliable Pharma Plans to Expand its Market The company has started its operations as a distributor in the critical…
PharmaState Updates – Latest Pharma Happenings Infalliable Pharma Plans to Expand its Market The company has started its operations as a distributor in the critical…
PharmaState Updates – Latest Pharma Happenings Innovation for Pharma Industry: Mansukh Mandaviya Union Health Minister stressed that research and innovation is a necessity for the…
PharmaState Updates – Latest Pharma Happenings Leverage global biosimilar opportunity In 2015 the Indian biosimilar market was around USD 300 mn, and it is expected…
PharmaState Updates – Latest Pharma Happenings UAE-based company willing to invest in Indian pharma firms Apart from Indian pharmaceutical market, Niner Pharma is also planning…
PharmaState Updates – Latest Pharma Happenings J B Chemicals & Pharmaceuticals to Buy Brands from Sanzyme Pvt Ltd. The acquisition cost is around Rs 628…
PharmaState Updates – Latest Pharma Happenings No Approval for Generic Paxlovid: SEC The Subject Expert Committee of India’s drug regulator rejected applications by Hetero Labs…
PharmaState Updates – Latest Pharma Happenings Pharma Marketing Influences Prescriptions of 98% Medical Doctors Out of 1100 Medical Doctors, 97.6% of doctors had entertained marketing…
PharmaState Updates – Latest Pharma Happenings Indian Pharma Companies Boost Drug Discovery Effort India’s health ministry has declared that a policy to mount research in…
PharmaState Updates – Latest Pharma Happenings Mankind Pharma enters into critical care segment The company’s Saviour Mankind division has products ranging from anti-infectives to trauma…
PharmaState Updates – Latest Pharma Happenings JAS India selects P. A. Sushil for the role of Sale Manager JAS India has appointed Padippurakkal Athayth Sushil…
Please confirm you want to block this member.
You will no longer be able to:
Please allow a few minutes for this process to complete.
You must be logged in to post a comment.